Center-Authored Papers

Filters: Author is Brooks, Jennifer D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Knight JA, Fan J, Malone KE, John EM, Lynch CF, Langballe R, Bernstein L, Shore RE, Brooks JD, Reiner AS et al..  2017.  Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.. International journal of cancer. Abstract
Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF et al..  2017.  Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.. Journal of the National Cancer Institute. 109(10) Abstract
B
Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE, Bernstein JL et al..  2012.  Body mass index and risk of second primary breast cancer: The WECARE Study.. Breast cancer research and treatment. 131(2):571-80. Abstract
Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE et al..  2016.  Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.. Cancer medicine. 5(11):3282-3291. Abstract
C
Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ et al..  2013.  Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.. Cancer causes & control : CCC. 24(8):1605-14. Abstract
H
Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L et al..  2017.  Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.. Breast cancer research : BCR. 19(1):83. Abstract
R
Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M et al..  2015.  Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.. SpringerPlus. 4:825. Abstract
Figueiredo JC, Brooks JD, Conti DV, Poynter JN, Teraoka SN, Malone KE, Bernstein L, Lee WD, Duggan DJ, Siniard A et al..  2011.  Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.. Breast cancer research and treatment. 127(3):819-29. Abstract
V
Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S et al..  2012.  Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.. Human mutation. 33(1):158-164. Abstract
Brooks JD, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P et al..  2013.  Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.. International journal of molecular epidemiology and genetics. 4(1):35-48. Abstract
Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjaer L, John EM, Malone KE, Reiner AS, Lynch CF, Concannon P et al..  2012.  Variation in genes related to obesity, weight and weight change and risk of contralateral breast cancer in the WECARE Study population.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(12):2261-2267. Abstract